Sheba Signs Collaborative Agreement with Regeneron

Today, Sheba Medical Center signed a collaborative agreement with Regeneron focusing on accelerating oncology research and delivering novel therapeutics.

“As we work to turn innovative science into needed medicines, we will partner with centers of excellence like Sheba that have established best practice clinical trial processes,” said David Weinreich, M.D., MBA, Executive Vice President, Global Clinical Development of Regeneron. “We know that fighting cancer requires cooperation from the best minds around the world.”

Regeneron will also sponsor Sheba’s ARC innovation center, where a “personalized medicine” development hub is creating cutting-edge solutions for patient care.

Watch here.

Whether helping those most in need or advancing healthcare globally:
when you support Sheba, you are making a difference.